drugset / Trial / NCT00371007

MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

NCT00371007

Phase 2 Completed 126 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy

Timeline

Start
2004-06-01
Primary completion
2005-04-25
Completion
2005-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule